A Call for Greater Education in Stem Cell TherapiesByMarco Meglio,Claire Henchcliffe, MD, DPhil,Roger A. Barker, MD, PhDJune 6th 2026
SKY-0515 Reduces mHTT, Alexion C5 inhibitors Reduces Relapse Rate, Exploring Stem Cell Innovation in PDByNeurologyLive® StaffJune 6th 2026
Discontinuing Disease-Modifying Therapy in Older Patients With MS: John Corboy, MDByJohn Corboy, MD,Isabella Ciccone, MPHJune 5th 2026
Stem Cell Therapy Versus Traditional Parkinson TreatmentsByMarco Meglio,Claire Henchcliffe, MD, DPhil,Roger A. Barker, MD, PhDJune 5th 2026
Considering Cladribine Treatment for Older Adults With Relapsing MS: Amy Gutierrez, MD, FAANByAmy Gutierrez, MD, FAAN,Isabella Ciccone, MPHJune 4th 2026